<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0004987"><a href="http://purl.obolibrary.org/obo/MONDO_0004987">MONDO:0004987</a></h3>
<p><strong>Label:</strong> bladder tumor</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0001187">MONDO:0001187</a> (urinary bladder cancer), <a href="http://purl.obolibrary.org/obo/MONDO_0004986">MONDO:0004986</a> (bladder carcinoma (disease)),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_109800">OMIM:109800</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0025033">HP:0025033</a> (Abnormality of digestive system morphology))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0025031">HP:0025031</a> (Abnormality of the digestive system))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012718">HP:0012718</a> (Morphological abnormality of the gastrointestinal tract))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011024">HP:0011024</a> (Abnormality of the gastrointestinal tract))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002250">HP:0002250</a> (Abnormality of the large intestine))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002242">HP:0002242</a> (Abnormality of the intestine))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100242">HP:0100242</a> (Sarcoma))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0031093">HP:0031093</a> (Abnormal breast morphology))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011792">HP:0011792</a> (Neoplasm by histology))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000769">HP:0000769</a> (Abnormality of the breast))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000078">HP:0000078</a> (Abnormality of the genital system))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100242">HP:0100242</a> (Sarcoma))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0031093">HP:0031093</a> (Abnormal breast morphology))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011792">HP:0011792</a> (Neoplasm by histology))) 100.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0006740">HP:0006740</a> (Transitional cell carcinoma of the bladder) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000769">HP:0000769</a> (Abnormality of the breast))) 100.00%</li>
</ul>
</body>
</html>
